Patil Amol E, Shetty Yashashri C, Gajbhiye Snehalata V, Salgaonkar Sweta V
Department of Pharmacology and Therapeutics, Seth G.S. Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Department of Anaesthesia, Seth G.S. Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Indian J Anaesth. 2015 Nov;59(11):721-7. doi: 10.4103/0019-5049.170032.
When a drug is used in a way that is different from that described in regulatory body approved drug label, it is said to be 'off label use'. Perioperative phase is sensitive from the point of view of patient safety and off-label drug use in this setup can prove to be hazardous to patient. Hence, it was planned to assess the pattern of drug utilisation and off-label use of perioperative medication during anaesthesia.
Preoperatively, demographic details and adverse events check list were filled from a total of 400 patients from general surgery, paediatric surgery and orthopaedics departments scheduled to undergo surgery. The perioperative assessment form was assessed to record all prescriptions followed by refilling of adverse events checklist in case record form. World Health Organization (WHO) prescribing indicators were used for analysis of drug utilisation data. National Formulary of India 2011 was used as reference material to decide off-label drug use in majority instances along with package insert.
A total of 3705 drugs were prescribed to the 400 participants and average number of drugs per patient was 9.26 ± 3.33. Prescriptions by generic name were 68.07% whereas 85.3% drugs were prescribed from hospital schedule. Off-label drugs overall formed 20.19% of the drugs prescribed. At least one off-label drug was prescribed to 82.5% of patients. Inappropriate dose was the most common form of off-label use. There was 1.6 times greater risk of occurrence of adverse events associated with the use of off-label drugs.
Prescription indicators were WHO compliant. Off-label drug use was practiced in anaesthesia department with questionable clinical justification in some instances.
当一种药物的使用方式与监管机构批准的药品标签中所描述的方式不同时,就被称为“标签外使用”。从患者安全的角度来看,围手术期是敏感的,在此阶段进行标签外用药可能对患者有害。因此,计划评估麻醉期间围手术期用药的药物使用模式和标签外使用情况。
术前,从计划接受手术的普通外科、小儿外科和骨科的400名患者中填写人口统计学细节和不良事件检查表。评估围手术期评估表以记录所有处方,随后在病例记录表中重新填写不良事件检查表。使用世界卫生组织(WHO)的处方指标来分析药物使用数据。在大多数情况下,以2011年印度国家处方集作为参考资料,并结合药品说明书来确定标签外用药情况。
共为400名参与者开具了3705种药物,每位患者的平均用药数量为9.26±3.33。通用名处方占68.07%,而85.3%的药物是根据医院处方开具的。标签外药物总体上占所开药物的20.19%。至少有82.5%的患者使用了一种标签外药物。剂量不当是最常见的标签外使用形式。使用标签外药物发生不良事件的风险高1.6倍。
处方指标符合WHO标准。麻醉科存在标签外用药情况,在某些情况下临床合理性存疑。